MSD Principal Scientist Sterile Drug Product Commercialization 

United States, Pennsylvania, Upper Gwynedd Township 

159971857

Principal Scientist, Sterile Drug Product Commercialization

As part of Our Company’s Manufacturing Division, the Sterile Drug Product Commercialization group provides the technical process leadership and laboratory capabilities for late stage and commercial drug product processes for vaccines, biologics, and sterile pharmaceutical products. It is the division’s leader in sterile product and process development, responsible for late-stage commercialization activities including process scale up, technology transfer to internal and external sites, process validation, authoring of regulatory submissions and support of significant manufacturing investigations. The group is responsible for establishing the science, engineering and knowledge required for today’s innovative and accelerated commercialization of novel vaccines, biologics, and pharmaceutical products and combination products.

What you will do:

• Execute and provides oversight to LVV product and process design, development, characterization, technology transfer, and robust commercial validation.

• Serve on cross functional drug product (DP) working group and supports LVV lyophilized DP activities through filing and Process Performance Qualification (PPQ), site characterization plan and execution, tech transfer control strategy, process development, PPQ readiness, PAI (Pre‐Approval Inspection) readiness, approval, launch and post‐launch support.

• Ensure commercialization program meet requirements related to science, quality, reliability, schedule, and cost.

• Provide mentorship, technical oversight, and strategic guidance with respect to LVV process optimization. Uses advanced experience gained on scientific/technical issues to guide others to address complex technical challenges.

• Develop a process and product development plan. Influences decisions related to primary packaging and combination product design.

• Innovate and drive best practices for commercial site tech transfer, facility fit and development of the DP control strategy. Includes the classification of process parameters, performance parameters, operating ranges, in-process controls. Drive and influence process demonstration and qualification (PPQ) and shelf-life strategies.

• Influence CMC regulatory strategy and author DP CMC sections of filing. Review regulatory strategy and filing readiness and support preparation for agency meetings. Author and review regulatory submissions.

• Create the best and next practices in LVV process scale down, parameter finding, site characterization and transfer.

• Establish and foster a culture of high performance, out of the box thinking, innovation and learning, empowerment, diversity and inclusion.

Education:

• B.S. in Chemical Engineering, Biochemical Engineering Bio-engineering, Pharmaceuticals, Biochemistry, Microbiology, or related field with 12 years of relevant experience; or

• Master's degree in Chemical Engineering, Biochemical Engineering Bio-engineering, Pharmaceuticals, Biochemistry, Microbiology, or related field with 10 years of relevant experience; or

• Ph.D. in Chemical Engineering, Biochemical Engineering, Bio-engineering, Pharmaceuticals, Biochemistry, Microbiology, or related field with 8 years of relevant experience

Preferred Experience and Skills

• Vaccine background including comprehensive knowledge and hands on experience in live virus vaccines.

• Working knowledge in cell-based assays for live-virus vaccines such as reporter gene assays, TCID50, plaque, and infectivity.

• Experience with the manufacturing of sterile drug products (vaccines, biologics) at the pilot or commercial scale.

• Working knowledge of cGMPs for manufacturing of sterile dosage forms and current ICH Quality norms as applied in Manufacturing Science and Technology or Technical Operations. Technical expertise in sterile drug product fill finish related manufacturing processes for large molecules, including laboratory and/or fundamental models for key unit operations.

• Experience with technology transfer and scale-up of processes to pilot and/or manufacturing scales.

• Excellent oral and written communication skills. Ability to effectively articulate understanding of process science, to drive decision making, impact assessments, design of studies, etc., in a multi-disciplinary team environment.

• Experience in LVV drug product fill finish process optimization, scale-up and technology transfer of sterile products to pilot/commercial.

• Operations experience in the manufacturing of sterile drug products, at pilot and/or commercial scale.

• Working knowledge of regulatory requirements for commercialization and registration of sterile drug products, including application of Quality by Design principles

• Working knowledge of statistical methods for DOE design and data analysis, statistical process control (SPC), multivariate analysis (MVA), and/or process analytical technologies (PAT) techniques for manufacturing processes

• Experience in Data Analytics, Computer Modeling, and Digital Applications (e.g. 3-D printing).

• Working understanding of analytical methods to characterize vaccines, biologics and other sterile drug products.

This position may require travel up to 25- 50%; Must be able to travel for this position.

NOTICE FOR INTERNAL APPLICANTS

In accordance with all employees subject to this policy are required to have a minimum of twelve (12) months of service in current position prior to applying for open positions.

If you have been offered a separation benefits package, but have not yet reached your separation date and are offered a position within the salary and geographical parameters as set forth in the Summary Plan Description (SPD) of your separation package, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent Acquisition Advisor.

Employees working in roles that the Company determines require routine collaboration with external stakeholders, such as customer-facing commercial, or research-based roles, will be expected to comply not only with Company policy but also with policies established by such external stakeholders (for example, a requirement to be vaccinated against COVID-19 in order to access a facility or meet with stakeholders). Please understand that, as permitted by applicable law, if you have not been vaccinated against COVID-19 and an essential function of your job is to call on external stakeholders who require vaccination to enter their premises or engage in face-to-face meetings, then your employment may pose an undue burden to business operations, in which case you may not be offered employment, or your employment could be terminated. Please also note that, where permitted by applicable law, the Company reserves the right to require COVID-19 vaccinations for positions, such as in Global Employee Health, where the Company determines in its discretion that the nature of the role presents an increased risk of disease transmission.

Current Contingent Workers apply

US and Puerto Rico Residents Only:

if you need an accommodation during the application or hiring process.

U.S. Hybrid Work Model

Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, generally Tuesday, Wednesday and either Monday or Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by aagreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as “remote”.

Not Applicable1st - Day

*A job posting is effective until 11:59:59PM on the dayBEFOREthe listed job posting end date. Please ensure you apply to a job posting no later than the dayBEFOREthe job posting end date.

A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.